The NCCN Criterion 'Young Age at Onset' Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population

Autor: Elmira Ebrahimi, Reza Ghiasvand, Iraj Harirchi, Kazem Zendehdel, Mohammad R. Akbari, Elham Mohebbi, Erin Sellars, Reza Shirkoohi
Rok vydání: 2019
Předmět:
Adult
0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
PALB2
Population
Breast Neoplasms
Iran
Iranian population
Young Adult
03 medical and health sciences
0302 clinical medicine
Breast cancer
Mutation Rate
Neoplastic Syndromes
Hereditary

Internal medicine
Humans
Medicine
Genetic Predisposition to Disease
Genetic Testing
Age of Onset
skin and connective tissue diseases
education
Germ-Line Mutation
Genetic testing
BRCA2 Protein
education.field_of_study
medicine.diagnostic_test
BRCA1 Protein
business.industry
Pathogenic mutation
Carcinoma
Ductal
Breast

High-Throughput Nucleotide Sequencing
Middle Aged
Prognosis
medicine.disease
Carcinoma
Lobular

Young age
030104 developmental biology
030220 oncology & carcinogenesis
Female
Fanconi Anemia Complementation Group N Protein
business
Follow-Up Studies
Hereditary Breast Cancer
Zdroj: Cancer Prevention Research. 12:763-770
ISSN: 1940-6215
1940-6207
Popis: Because the contribution of genetic factors to the burden of breast cancer is not well investigated in Iran, we aimed to examine the prevalence of mutations in breast cancer susceptibility genes, BRCA1/2 and PALB2, and to investigate the predictive potential of hereditary breast cancer risk criteria for genetic testing in Iranian population. Next-generation sequencing was conducted on a population consisting of 299 and 125 patients with breast cancer, with and without hereditary cancer risk criteria for genetic testing, respectively. The pathogenic mutation frequency rate was 10.7% in patients with hereditary cancer criteria versus 1.6% in no criteria group (P = 0.0017). None of the 107 tested patients with only young age at onset (
Databáze: OpenAIRE